Pathogenetic Dichotomy in Angioleiomyoma

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Angioleiomyoma is a benign tumor with limited known genetic information.
• Previous studies identified few genetic abnormalities, including chromosomal losses and gains, and mutations in specific genes.
• This study investigates genetic findings in three additional angioleiomyoma cases.

Purpose of the Study:

• To identify novel genetic alterations and pathways in angioleiomyomas.
• To characterize the molecular consequences of observed chromosomal translocations.
• To contribute to a better understanding of the genetic basis of angioleiomyoma.

Main Methods:

• G-banding and karyotyping for chromosomal analysis.
• RNA sequencing and reverse transcription-polymerase chain reaction for gene expression analysis.
• Sanger sequencing for mutation analysis.

Main Results:

• A novel t(4;5)(p12;q32) translocation was found, creating a CARMN::TXK fusion gene and leading to TXK overexpression.
• A four-way translocation t(X;3;4;16)(q22;p11;q11;p13) resulted in enhanced IRS4 expression.
• A third tumor showed a t(X;9)(q22;q32) rearrangement at chromosome band Xq22.

Conclusions:

• Two recurrent genetic pathways in angioleiomyoma are identified: t(4;5)(p12;q32) translocation leading to CARMN::TXK chimera and Xq22 rearrangement causing IRS4 overexpression.
• These findings expand the understanding of angioleiomyoma genetics.
• The study highlights the importance of cytogenetic and molecular analyses in characterizing benign tumors.